BFLY vs. ACRS

In the year-to-date period, BFLY achieves a -24.68% return, which is significantly higher than ACRS's -49.60% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for Butterfly Network, Inc. (BFLY) and Aclaris Therapeutics, Inc. (ACRS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current BFLY Sharpe Ratio is 1.35, which is higher than the ACRS Sharpe Ratio of 0.07. The chart below compares the historical Sharpe Ratios of BFLY and ACRS, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither BFLY nor ACRS has paid dividends to shareholders.

The maximum BFLY drawdown since its inception was -97.40%, roughly equal to the maximum ACRS drawdown of -98.05%. Use the drawdown chart below to compare losses from any high point for BFLY and ACRS. For additional features, visit the drawdowns tool.

The current volatility for Butterfly Network, Inc. (BFLY) is 15.26%, while Aclaris Therapeutics, Inc. (ACRS) has a volatility of 21.17%. This indicates that BFLY experiences smaller price fluctuations and is considered to be less risky than ACRS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between Butterfly Network, Inc. and Aclaris Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.